Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
2024 · Journal of the National Comprehensive Cancer Network · 459 citations
https://doi.org/10.6004/jnccn.2024.0035
R
Rachel C. Jankowitz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
163
Papers
6.1K
Citations
34
h-index
60
i10-index
Rachel C. Jankowitz is an academic researcher from Magee-Womens Research Institute. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & Epigenetics and DNA Methylation. The author has an h-index of 34, co-authored 139 publications.
ORCID: 0000-0001-7691-2389Papers by this author
worksNCCN Guidelines® Insights: Breast Cancer, Version 4.2023
2023 · Journal of the National Comprehensive Cancer Network · 409 citations
https://doi.org/10.6004/jnccn.2023.0031
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
2020 · Nature Genetics · 186 citations
https://doi.org/10.1038/s41588-019-0537-1
Prediction of Breast and Prostate Cancer Risks in Male <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers Using Polygenic Risk Scores
2017 · Journal of Clinical Oncology · 181 citations
https://doi.org/10.1200/jco.2016.69.4935
Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer
2019 · Nature Communications · 138 citations
https://doi.org/10.1038/s41467-018-08053-5
Epigenetics in breast cancer: what's new?
2011 · Breast Cancer Research · 131 citations
https://doi.org/10.1186/bcr2925
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat